Digest Network Come funziona
Network
/
Società
UN
Non verificato

UNION therapeutics

Di cosa scriviamo

BiologiaFarmaceuticaFinanzaSanità

4 comunicati stampa

Guarda tutti i comunicati
21/02/2025
Farmaceutica
Sanità
Finanza
Biologia
UNION therapeutics announces presentation of preliminary data from Phase 2a investigator-initiated study with orismilast in ulcerative colitis at the 20th ECCO Congress
Fonte
UNION therapeutics
Emittente
PR News Wire
1.00
0
25/09/2024
Farmaceutica
Sanità
Biologia
UNION therapeutics announce results from the ADESOS Phase 2b study in atopic dermatitis confirming the potential of orismilast as a first-in-class safe and efficacious oral treatment
Fonte
UNION therapeutics
Emittente
PR News Wire
1.00
0
20/09/2024
Farmaceutica
Sanità
Finanza
Biologia
UNION therapeutics to present orismilast Phase 2b results in atopic dermatitis as a late-breaking oral presentation at the EADV Congress 2024
Fonte
UNION therapeutics
Emittente
PR News Wire
1.00
0
04/06/2024
Farmaceutica
Sanità
Biologia
UNION therapeutics announces successful completion of the ADESOS Phase 2b study and presentation of data at the RAVE Conference 2024
Fonte
UNION therapeutics
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0